Search results for "tips"

showing 10 items of 280 documents

Determination of Drug Concentrations in Serum and Dopamine Receptor Occupancy in Brain for Optimal Antipsychotic Drug Therapy

2009

Evidence has been given that antipsychotic effects of dopamine receptor antagonists are associated with 60 and 80% striatal dopamine D2 and D3 receptor occupancy. Receptor occupancy correlates well with concentrations of the antipsychotic drugs in serum or plasma, much better than the dose. The latter is consistent with weak correlations between antipsychotic dose and serum concentrations and explained by the high interindividual variabilities in drug metabolism. Using positron emission tomography (PET) for in vivo determination of dopamine receptor occupancy in conjunction with drug concentration measurements “therapeutic windows” could be calculated for the atypical antipsychotic drugs am…

medicine.diagnostic_testbusiness.industrymedicine.drug_classAtypical antipsychoticPharmacologyPsychiatry and Mental healthDopamine receptorDopamine receptor D3Therapeutic drug monitoringAnesthesiaMedicineZiprasidoneAripiprazoleAmisulpridebusinessClozapinemedicine.drugEuropean Psychiatry
researchProduct

Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysi…

2010

In recent years, combinations of pharmacological treatments have become common for the treatment of bipolar disorder type I (BP I); however, this practice is usually not evidence-based and rarely considers monotherapy drug regimen (MDR) as an option in the treatment of acute phases of BP I. Therefore, we evaluated comparative data of commonly prescribed MDRs for both manic and depressive phases of BP I. Medline, PsycINFO, EMBASE, the Cochrane Library, the ClinicalStudyResults.org and other data sources were searched from 1949 to March 2009 for placebo and active controlled randomized clinical trials (RCTs). Risk ratios (RRs) for response, remission, and discontinuation rates due to adverse …

medicine.medical_specialtyBipolar I disorderBipolar DisorderDatabases FactualPharmacologyLithiumArticlelaw.inventionTreatment of bipolar disorderRandomized controlled triallawInternal medicinemental disordersmedicineAnimalsHumansManic-depressive illnessPharmacology (medical)Bipolar disorderAntipsychotic drugsRandomized Controlled Trials as TopicPharmacologyTrastorn bipolarbusiness.industrymedicine.diseaseLitiAntidepressive AgentsDiscontinuationPsychiatry and Mental healthAcute DiseaseNumber needed to treatAnticonvulsiusQuetiapineDrug EvaluationAntipsicòticsAnticonvulsantsmedicine.symptombusinessManiamedicine.drug
researchProduct

Neurocognition in bipolar disorders—A closer look at comorbidities and medications

2010

The last decade has witnessed a growing interest in the neuropsychological study of bipolar disorder (BD). This chronic mood disorder is associated with persistent neurocognitive impairments even during periods of euthymia, particularly in the broad domains of attention, verbal memory and executive functions. More interestingly, cognitive dysfunction seems to predict a poorer functional outcome among BD patients and thus represents an important target for future therapies. The aetiology of cognitive dysfunction is probably multifactorial, including gene-environment interactions with potentially confounding variables as well. Drug-induced cognitive adverse effects represent an important and …

medicine.medical_specialtyBipolar disorderComorbidityLithiumAntipsychoticNeuropsychologyAnticonvulsantmedicineAnimalsHumansBipolar disorderPsychiatryPharmacologyNeuropsychologyCognitionIatrogenic effectmedicine.diseaseExecutive functionsComorbidityPharmaceutical PreparationsObservational studyVerbal memoryCognition DisordersPsychologyNeurocognitiveClinical psychologyEuropean Journal of Pharmacology
researchProduct

International prescribing practices in obsessive-compulsive disorder (OCD)

2016

Objectives To assess rates of psychotropic medication use in patients with obsessive–compulsive disorder (OCD) in seven different countries on five continents and to compare these with international treatment guidelines. Methods Researchers in the field of OCD were invited to contribute summary statistics on the characteristics of their patients with OCD and on their incidence of psychotropic use. Consistency of summary statistics across countries was evaluated. Results The data came from Brazil (n = 955), Italy (n = 750), South Africa (n = 555), Japan (n = 382), Australia (n = 213), India (n = 202) and Spain (n = 82). The majority (77.9%; n = 2445) of the total sample of 3139 participants …

medicine.medical_specialtyClomipraminemedicine.drug_classbusiness.industryIncidence (epidemiology)Atypical antipsychoticPsychotropic medicationmedicine.disease030227 psychiatry03 medical and health sciencesPsychiatry and Mental health0302 clinical medicinePharmacotherapyNeurologymedicinePharmacology (medical)In patientNeurology (clinical)PsychiatrybusinessProspective cohort studyObsessive-compulsive disorder (OCD)030217 neurology & neurosurgerymedicine.drugHuman Psychopharmacology: Clinical and Experimental
researchProduct

Chronic oral haloperidol and clozapine in rats: A behavioral evaluation.

1999

The present study evaluated chronic oral treatment of rats with haloperidol or clozapine. Drugs were given in the drinking water for a 23-day period . Rat behavior was analyzed once a week in an open field. Rats ingested either 1.7 mg/kg haloperidol or 40 mg/kg clozapine daily. Blood serum analysis revealed concentrations of 6 ng/ml for haloperidol and 22 ng/ml for clozapine at the end of the treatment. Haloperidol decreased overall activity from the onset of treatment. Clozapine showed similar effects only on the last test day. Control animals showed a slight habituation in exploration-related parameters. In conclusion, these results indicate that oral drug administration through the drink…

medicine.medical_specialtyDyskinesia Drug-InducedTime FactorsAdministration OralPharmacologyWeight GainOpen fieldRats Sprague-DawleyBlood serumOral administrationInternal medicinemedicineHaloperidolAnimalsHabituationHabituation PsychophysiologicClozapineBiological PsychiatryClozapineAnalysis of VarianceBehavior Animalbusiness.industryAntagonistRatsPsychiatry and Mental healthNeuropsychology and Physiological PsychologyEndocrinologyExploratory BehaviorHaloperidolFemaleAnalysis of variancebusinessLocomotionmedicine.drugAntipsychotic AgentsNeuropsychobiology
researchProduct

Assessment and management of agitation in psychiatry: Expert consensus

2016

International audience; BACKGROUND:Psychomotor agitation is associated with different psychiatric conditions and represents an important issue in psychiatry. Current recommendations on agitation in psychiatry are not univocal. Actually, an improper assessment and management may result in unnecessary coercive or sedative treatments. A thorough and balanced review plus an expert consensus can guide assessment and treatment decisions.METHODS:An expert task force iteratively developed consensus using the Delphi method. Initial survey items were based on systematic review of the literature. Subsequent surveys included new, re-worded or re-rated items.RESULTS:Out of 2175 papers assessing psychomo…

medicine.medical_specialtyEmergency Medical ServicesConsensusPsychomotor agitationassessmentDelphi methodverbal de-escalation03 medical and health sciencesBenzodiazepines0302 clinical medicineMeta-Analysis as TopicRisk FactorsmedicineHumansPsychiatryPsychomotor AgitationBiological PsychiatryAgitation assessment psychiatric emergency restraint verbal de-escalationRandomized Controlled Trials as TopicPsychiatric Status Rating ScalesPsychiatryAgitationTask forceExpert consensusDisease ManagementEvidence-based medicinepsychiatric emergency3. Good health030227 psychiatryAgitation; assessment; psychiatric emergency; restraint; verbal de-escalation; Biological Psychiatry; Psychiatry and Mental HealthOlanzapinePsychiatry and Mental Healthrestraint[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthPractice Guidelines as TopicTreatment decision makingmedicine.symptomBiological psychiatryPsychology030217 neurology & neurosurgeryAntipsychotic Agents
researchProduct

Pharmacological treatment of sexual offenders in German outpatient treatment centers

2018

In Germany, depending on a sexual offender's culpability and the severity of the offence, he/she can be placed either in the forensic-psychiatric or the correctional system. Numbers related to the pharmacological treatment of sexual offenders for the correctional system are missing so far. In sexual offenders, the pharmacological treatment of paraphilic disorders is of special importance. The present study aimed at assessing the prevalence of pharmacological sexual offender treatment in German outpatient treatment centers supervising mainly clients from the correctional sector. An online questionnaire was sent to 112 outpatient treatment centers and 21 provided data relevant for the present…

medicine.medical_specialtyMEDLINEComputer-assisted web interviewingPharmacological treatmentGerman03 medical and health sciences0302 clinical medicineGermanyOutpatientsAmbulatory CarePrevalencemedicineHumansPharmacology (medical)PsychiatryParaphilic Disorders0505 lawParaphilic Disordersbusiness.industryMental DisordersSex Offenses05 social sciencesCriminalsDrug Utilizationlanguage.human_language030227 psychiatryPsychiatry and Mental healthMulticenter study050501 criminologylanguagebusinessFacilities and Services UtilizationSelective Serotonin Reuptake InhibitorsAntipsychotic AgentsCulpabilityInternational Clinical Psychopharmacology
researchProduct

Induction of c-fos gene expression by the selective sigma receptor ligand EMD 57445 in rat brain.

1996

Based on animal studies it has been reasoned that ligands to sigma binding sites might be effective in the treatment of schizophrenic disorders and may also be used to investigate this largely elusive disorder on a molecular level. Expression patterns of c-fos in rat brain were studied following treatment with single doses of the sigma ligand EMD 57445 (0.3, 1, 3, 30 mg/kg s.c.). Specific c-fos gene expression was detected at all concentrations tested in various cortical areas. The signals observed were dose-dependent with the highest intensities in the piriform cortex. Strong signals were also detected in hippocampal areas CA 1,2,3 and the gyrus dentatus, as well as in the medial habenula …

medicine.medical_specialtyMammillary bodyNucleus accumbensHippocampal formationc-FosHippocampusRats Sprague-DawleyPiperidinesPiriform cortexInternal medicinemedicineAnimalsReceptors sigmaPharmacology (medical)OxazolesBiological PsychiatryIn Situ HybridizationPharmacologybiologyDose-Response Relationship DrugChemistryOlfactory tubercleBrainRatsPsychiatry and Mental healthEndocrinologyNeurologyHypothalamusIslands of Callejabiology.proteinFemaleNeurology (clinical)Proto-Oncogene Proteins c-fosAntipsychotic AgentsEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

Chronical haloperidol and clozapine treatment in rats: Differential RNA display analysis, behavioral studies and serum level determination

1998

1. Adult, female rats were treated orally for 23 days with 1.6 mg/kg haloperidol or 36 mg/kg clozapine per day, to study chronic effects of the two neuroleptics. 2. At five time points during the neuroleptic treatment, animal behavior was recorded in an open field and locomotive activity was analysed. At the end of the experiment, rats were decapitated, blood samples were collected and serum concentrations of haloperidol and clozapine were determined by a radioreceptor or HPLC assay, respectively. RNA was isolated from each brain, without cerebellum, and subjected to differential RNA display. 3. Mean serum concentrations were 8 ng/ml for haloperidol and 21 ng/ml for clozapine. Analysis of o…

medicine.medical_specialtyMotor ActivityPharmacologyPolymerase Chain ReactionOpen fieldRats Sprague-DawleyPharmacokineticsOral administrationInternal medicineGene expressionmedicineHaloperidolAnimalsRNA MessengerClozapineBiological PsychiatryClozapineDNA PrimersPharmacologybusiness.industryAntagonistBrainRNARatsEndocrinologyHaloperidolFemalebusinessAntipsychotic Agentsmedicine.drugProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Antipsychotic prescription and mortality in hospitalized older persons

2017

Background Recent scientific reports have shown that older persons treated with antipsychotics for dementia-related behavioural symptoms have increased mortality. However, the impact of these drugs prescribed during hospitalization has rarely been assessed. We aimed to investigate whether antipsychotics are associated with an increased risk of mortality during hospitalization and at 3-month follow-up in elderly inpatients. Methods We analyzed data gathered during two waves (2010 and 2012) by the REPOSI (Registro Politerapie Societa Italiana Medicina Interna). All new prescriptions of antipsychotic drugs during hospitalization, whether maintained or discontinued at discharge, were collected,…

medicine.medical_specialtyMultivariate analysis030214 geriatricsbusiness.industrymedicine.medical_treatmentmedicine.diseaseLogistic regression03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineRating scaleNormal cognitionInternal medicinemedicineHaloperidolDementiaGeriatrics and GerontologyMedical prescriptionAntipsychoticbusinessPsychiatryGerontology030217 neurology & neurosurgerymedicine.drugPsychogeriatrics
researchProduct